Profen and Ranolazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Ranolazine (ranolazine). Common drug interactions include carotid artery occlusion among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Ranolazine. It is created by eHealthMe based on reports of 80 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Ranolazine?

Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.



On Jul, 20, 2026

80 people who take Profen and Ranolazine together, and have interactions are studied.

Profen and Ranolazine drug interactions.

What are the common drug interactions of Profen and Ranolazine, by gender? *:

female:

  1. Carotid artery occlusion (artery blockage)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Cerebral atrophy (decrement in size of brain)
  4. Dizziness
  5. Head injury
  6. Idiopathic pulmonary fibrosis (chronic lung disease)
  7. Low density lipoprotein increased (cholesterol increased in blood)
  8. Mitral valve incompetence (inefficient heart valve)
  9. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  10. Rash

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Chest pain
  3. Fatigue (feeling of tiredness)
  4. Glossitis (infection of tongue with soreness)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Anaemia (lack of blood)
  7. Cardiac failure
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Memory impairment
  10. Mucosal inflammation (infection of mucous membrane)

What are the common drug interactions of Profen and Ranolazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Osteopenia (a condition where bone mineral density is lower than normal)
  2. Osteoporosis (bones weak and more likely to break)
  3. Renal injury (kidney injury)
  4. Spinal compression fracture (fracture due to spinal compression on bone)
  5. Chronic kidney disease
  6. Chest pain
  7. Insomnia (sleeplessness)
  8. Muscle twitching
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Back disorder

50-59:

  1. Age-related macular degeneration
  2. Cystoid macular oedema (fluid accumulation after cataract surgery)
  3. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)

60+:

  1. Chest pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Haematochezia (passage of stools containing blood)
  4. Pyrexia (fever)
  5. Fall
  6. Glossitis (infection of tongue with soreness)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Fatigue (feeling of tiredness)
  9. Dizziness
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. High Blood Pressure: 27 people, 33.75%
  2. High Blood Cholesterol: 25 people, 31.25%
  3. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 19 people, 23.75%
  4. Chest Pain: 18 people, 22.50%
  5. Stress And Anxiety: 17 people, 21.25%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 16.25%
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 13.75%
  8. Type 2 Diabetes: 11 people, 13.75%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 13.75%
  10. Oedema (fluid collection in tissue): 10 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Ranolazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Ranolazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranolazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranolazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and ranolazine (the active ingredients of Profen and Ranolazine, respectively), and Profen and Ranolazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: